Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
3.090
+0.050 (1.64%)
Apr 29, 2026, 10:42 AM EDT - Market open
Cyclerion Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 3.24 | 3.23 | 7.57 | 13.38 | 53.96 | Upgrade
|
| Cash & Short-Term Investments | 3.24 | 3.23 | 7.57 | 13.38 | 53.96 | Upgrade
|
| Cash Growth | 0.25% | -57.31% | -43.42% | -75.20% | -0.80% | Upgrade
|
| Receivables | 1 | 0.56 | - | 0.1 | 0.1 | Upgrade
|
| Prepaid Expenses | 0.38 | 0.42 | 0.44 | 0.81 | 0.93 | Upgrade
|
| Other Current Assets | 0.01 | 0.02 | 0.01 | 0.54 | 0.47 | Upgrade
|
| Total Current Assets | 4.64 | 4.23 | 8.02 | 14.82 | 55.46 | Upgrade
|
| Property, Plant & Equipment | - | - | - | 1.22 | 1.47 | Upgrade
|
| Long-Term Investments | 5.35 | 5.35 | 5.35 | - | - | Upgrade
|
| Other Long-Term Assets | - | - | - | 2.04 | 2.41 | Upgrade
|
| Total Assets | 9.99 | 9.58 | 13.37 | 18.08 | 59.33 | Upgrade
|
| Accounts Payable | 0.51 | 0.39 | 1.2 | 2.97 | 1.83 | Upgrade
|
| Accrued Expenses | 0.35 | 0.31 | 0.78 | 4.59 | 8.73 | Upgrade
|
| Other Current Liabilities | 0.04 | 0.03 | 0.11 | 0.07 | 0.53 | Upgrade
|
| Total Current Liabilities | 0.9 | 0.73 | 2.09 | 7.63 | 11.09 | Upgrade
|
| Total Liabilities | 0.9 | 0.73 | 2.09 | 7.63 | 11.09 | Upgrade
|
| Additional Paid-In Capital | 280.11 | 276.34 | 275.72 | 269.63 | 263.35 | Upgrade
|
| Retained Earnings | -271.02 | -267.49 | -264.42 | -259.15 | -215.08 | Upgrade
|
| Comprehensive Income & Other | - | - | -0.01 | -0.02 | -0.02 | Upgrade
|
| Shareholders' Equity | 9.09 | 8.85 | 11.29 | 10.45 | 48.25 | Upgrade
|
| Total Liabilities & Equity | 9.99 | 9.58 | 13.37 | 18.08 | 59.33 | Upgrade
|
| Net Cash (Debt) | 3.24 | 3.23 | 7.57 | 13.38 | 53.96 | Upgrade
|
| Net Cash Growth | 0.25% | -57.31% | -43.42% | -75.20% | 523.11% | Upgrade
|
| Net Cash Per Share | 1.02 | 1.28 | 3.24 | 6.16 | 27.57 | Upgrade
|
| Filing Date Shares Outstanding | 4.23 | 2.55 | 2.54 | 2.18 | 2.17 | Upgrade
|
| Total Common Shares Outstanding | 3.82 | 2.55 | 2.47 | 2.18 | 2.17 | Upgrade
|
| Working Capital | 3.74 | 3.5 | 5.94 | 7.19 | 44.37 | Upgrade
|
| Book Value Per Share | 2.38 | 3.48 | 4.56 | 4.80 | 22.23 | Upgrade
|
| Tangible Book Value | 9.09 | 8.85 | 11.29 | 10.45 | 48.25 | Upgrade
|
| Tangible Book Value Per Share | 2.38 | 3.48 | 4.56 | 4.80 | 22.23 | Upgrade
|
| Machinery | - | - | - | - | 0.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.